期刊文献+

冠状静脉窦逆行灌注血管内皮生长因子基因对心肌梗死兔心电稳定性的影响 被引量:2

Effect of retrograde coronary sinus perfusion pAdtrackCMV-VEGF_(165) on electrical stability of ischemic ventricular myocardium in rabbit infarction model
下载PDF
导出
摘要 目的观察经冠状静脉窦逆行灌注血管内皮生长因子基因(pAdtrackCMV-VEGF165)对心肌梗死兔心电稳定性的影响。方法20只新西兰大白兔随机分为实验组(基因治疗组)和对照组,两组动物常规全麻,暴露心脏,结扎左室支建立心肌梗死模型,冠状静脉窦插管,实验组逆行灌注pAdtrackCMV-VEGF165,对照组以生理盐水对照,2周后于右室心尖部及流出道行心内程序刺激,观察心律失常诱发情况,并检测左室前壁心肌血管密度。结果对照组恶性心律失常的诱发率显著高于实验组(77.78%vs30.00%,P<0.01);基因治疗组心肌血管密度明显高于对照组(P<0.01)。结论经冠状静脉窦逆行灌注pAdtrackCMV-VEGF165可增加缺血心肌内血管密度,提高缺血心肌的心电稳定性,减少严重心律失常的发生。 Objective To compare the electrical stability of ischemic ventricular myocardium in rabbit infarction model with or without vascular endothelial growth factor (VEGF). Methods Twenty Newzland rabbits were divided into 2 groups, general anesthesia and open thorax, elevating the apex of the heart, clamping the main stem of left ventricular coronary. pAdtrackCMV-VEGFl65 were retrograde perfused through coronary sinus in experiment group, and nature saline was used in control group. Multi-step programmed electrical stimulation was performed in right ventricular apex and outflow tract in all rabbits 2 weeks later. The instances of malignant arrhythmia, capillary density were detected. Results The instance of malignant arrhythmia induced in control group was significantly higher than that in experiment group(77.78% vs 30.00% ,P 〈0.01 ). Meanwhile,the capillary density of the ischemic zone in gene therapy group was much more than that in control group(P 〈 0.05 ). Conclusion Retrograde coronary sinus perfusion pAdtrackCMV-VEGFl65 can improve the capillary density of the ischemic myocardium as well as the ventricular electrical stability ,and thus decrease the incidence of malignant arrhythmia.
出处 《中国心脏起搏与心电生理杂志》 2008年第4期344-346,共3页 Chinese Journal of Cardiac Pacing and Electrophysiology
关键词 心血管病学 冠状静脉窦逆行灌注 血管内皮生长因子 心肌梗死 基因治疗 程序电刺激 恶性心律失常 Cardiology Retrograde coronary sinus perfusion Vascular endothelial growth factor Rabbit Myocardial infarction Gene therapy Programmed stimulation Malignant arrhythmia
  • 相关文献

参考文献9

  • 1Leung DW, Cachlanes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen [ J]. Science, 1989, 246:1 306
  • 2Castilla MA, Caramelo C, Gazapo RM, et al. Role of vascular endothelial growth factor(VEGF) in endothelial cell rotection against cytotocic agents[ J]. Life Sciences ,2000,67 : 1 003
  • 3Matsunaga T, Warltier DC, Weihraunch DW, et al. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide [ J ]. Circulation ,2000,102:3 098
  • 4Banal S, Taklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs [ J ]. Circulation, 1994,89:2 183
  • 5Fitzgerald D, Friday K J, Yeung-lai-wah J, et al. Myocardial region of slow conduction participating in the reentrant circuit of multiple ventricular tachycardias : report on ten patients [ J ]. J Cardiovasc Electriphysiol, 1991,2 : 193
  • 6Sato K, Wu T, Laham R J, et al. Efficacy of intracoronary or intravenous VEGF(inf) 165</inf> in a pig model of chronic myocardial ischemia[ J ]. JACC ,2001,37:616
  • 7韦方,邓云坤,乔慧.人VEGF165基因的克隆、表达和活性鉴定[J].贵州医药,2005,29(1):3-6. 被引量:2
  • 8韦方,耿庆山,冯建章,林华欢,蒋祖勋,余细勇,周钢.转VEGF基因对血管损伤后修复过程中基质金属蛋白酶表达的影响[J].中国病理生理杂志,2003,19(1):64-67. 被引量:4
  • 9Rooprai HK, Rucklidge GJ, Panou C, et al. The effects of exogenous growth factor on matrix metalloproteinase secretion by human brain tumor cells[J]. Br J Cancer, 2000,82( 1 ) :52

二级参考文献14

  • 1(美)J萨姆布鲁克 E F.弗里奇 T.曼尼阿蒂斯著.金冬雁等译.分子克隆实验指南[M].科学出版社,1993.362.
  • 2F Fermra N , Henzel WJ. Pituitary follucular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun,1989,161:851-5.
  • 3Castilla MA,Caramelo C, Gazapo RM,et al. Role of vascular endothelial growth factor(VEGF) in endothelial cell protection against cytotocic agents. Life Sciences, 2000,67:1 003-1013.
  • 4Hojo Y, Ikeda U, Zhu Y, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol, 2000,35 :968 -973.
  • 5Forsythe J A, J iang BH, Lyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol, 1996,16:4 604-4613.
  • 6Kulak J, Jozkowicz A, Dembinska KA, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. ARTERIOSCLER-THROMB-VASC-BIOL, 2000, 20 (3) : 659-666.
  • 7Hirai Y, Migita K, Honda S, et al. Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells. LIFE SCI,2001,68(8) :913-920.
  • 8F Ferrara N , Henzel WJ. Pituitary follucular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun,1989,161:851-5.
  • 9Castilla MA,Caramelo C, Gazapo RM,et al. Role of vascular endothelial growth factor(VEGF) in endothelial cell protection against cytotocic agents. Life Sciences, 2000,67:1 003-1 013.
  • 10Hojo Y, Ikeda U, Zhu Y, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol, 2000,35:968 -973.

共引文献4

同被引文献10

  • 1HOCHMAN J S, LAMAS G A, BULLER C E, et al. Coronary intervention for persistent occlusion after myocardial infarction[J]. N Engl J Med, 2006, 355(23) : 2395-2407.
  • 2FONAROW G C, WRIGHT R S, SPENCER F A, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality [ J ]. Am J Cardiol, 2005, 96(5): 611-616.
  • 3MATSUNAGA T, WARLTIER D C, WEIHRAUNCH D W, et al. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide[J]. Circulation, 2000, 102(25) : 3098-3103.
  • 4SATO K, WU T, LAHAM R J, et al. Efficacy of intracoronary or intravenous VEGF 165 in a pig model of chronic myocardial ischemia[J]. JACC, 2001, 37(2): 616-623.
  • 5ROOPRAI H K, RUCKLIDGE G J, PANOU C, et al. The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumor cells [J]. Br J Cancer, 2000, 82(1) : 52-55.
  • 6KATRA R P, LAURITA K R. Cellular mechanism of calcium- mediated triggered activity in the heart [J]. Circ Res, 2005, 96(5) : 535-542.
  • 7ANDERSON K P. Lipid-lowering therapy for prevention of ventrieular taehyarrhythmias[J]. J Am Coil Cardiol, 2003, 42 (1):88-92.
  • 8SHIROSHITA-TAKESHITA A, SCHRAM G, LAVOIE J, et al. Effect of simvastatin and antioxidant vitamins on atrial fibrellation promotion by atri-al-tachycardia remodeling in dogs [J]. Circulation, 2004, 110(16) : 2313-2319.
  • 9TAMARGO J, CABALLER, GOMEZ R, et al. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy[J]. Pharmacol Ther, 2007, 114(1): 107-126.
  • 10韦方,袁明兰,周永刚,王树辉,王永梅,李世英.冠状静脉窦逆行灌注VEGF蛋白的实验研究[J].贵州医药,2008,32(6):499-500. 被引量:2

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部